As It Happens

Rich countries only shared 14% of COVID-19 vaccine doses promised to poorer nations: report

A coalition of human rights organizations lays the blame on pharmaceutical companies and rich countries like Canada for contributing to vaccine inequality around the world. 

'There just aren't enough vaccines being made,' says the policy lead on vaccine inequality for Oxfam Canada

Aid workers check a shipment of vaccines against the coronavirus sent to Sudan by the COVAX vaccine-sharing initiative in Khartoum on Oct. 6. (Ebrahim Hamid/AFP/Getty Images)

Read Story Transcript

A coalition of human rights organizations lays the blame on pharmaceutical companies and rich countries like Canada for contributing to vaccine inequality around the world. 

In a new report, the People's Vaccine Alliance — which includes Oxfam, ActionAid and Amnesty International — found that only one in seven COVID-19 vaccine doses promised to low-income countries were actually delivered.

The report found 261 million doses, or 14 per cent, of the 1.8 billion doses were delivered — and only 1.3 per cent of people in those countries are fully vaccinated.

"It just seems so wrong and so morally reprehensible to have huge swaths of the world unvaccinated just because they have less money," Brittany Lambert, policy lead on the vaccine inequality file for Oxfam Canada, told As It Happens host Carol Off.

"And for those [pharmaceutical] companies to be able to, you know, continue prioritizing the wealthy countries that are going to pay lots of money for these vaccines... People in developing countries don't have any less right to life and to health than the rest of us."

Canada has delivered eight per cent of the 40 million doses it pledged, the report says, while the U.K. has delivered 9.6 per cent of the 100 million doses it promised. The U.S. has delivered 16 per cent of the 1.1 billion vaccines it pledged.

These countries pledged to share doses through COVAX, the United Nations' global vacine-sharing initiative.

Major vaccine developing companies, including AstraZeneca, Johnson & Johnson, Moderna and Pfizer, pledged 994 million doses to COVAX, but so far only 12 per cent have been delivered, according to the report.

People register for a shot of the Moderna vaccine at Saint Damien Hospital in Port-au-Prince, Haiti on July 27. After months of not having any vaccines in the country, the U.S. donated 500,000 doses through the UN COVAX system. (Joseph Odelyn/The Associated Press)

In many low-income countries, Lambert said that even frontline health-care workers aren't vaccinated yet. 

Between January and May this year, COVID-19 may have killed between 80,000 and 180,000 health-care staff around the world, according to the World Health Organization (WHO).

Across Africa, less than one in 10 health-care workers were fully vaccinated, compared to eight in 10 in wealthy countries, the report found.

WHO director general Tedros Adhanom Ghebreyesus told BBC News that health-care workers must be prioritized for vaccines and criticized the distribution of doses. 

To Lambert, this global vaccine inequality was "entirely avoidable."

"The consequences of this, obviously, is tons of needless deaths, the ongoing toll on economies and on people's livelihoods in countries that were already struggling with poverty to begin with," Lambert said.

A nurse gives a shot of the Pfizer coronavirus vaccine to a World Health Organization worker at a clinic in Gaza City on on March 21. The vaccines were received through the global COVAX initiative to eligible people in the West Bank and Gaza Strip. (Adel Hana/The Associated Press)

This week's report, titled "A Dose of Reality," calls on G20 leaders to lift patents, share vaccine technology and let developing countries make their own vaccines. 

"The core of the problem is that there just aren't enough vaccines being made," Lambert said.

She says AstraZeneca, Johnson & Johnson, Moderna and Pfizer have a monopoly over vaccine production and have refused to share their recipe with other manufacturers who could expand production.

But governments, she said, have a responsibility in an emergency situation like this one. She says countries should use their legal tools to force COVID-19 vaccine developing companies to share their knowledge and technology and waive intellectual property rights.

South Africa and India proposed this temporary waiver to the World Trade Organization last year. More than 100 countries, including the U.S., have backed the waiver since then, but a few, including the U.K. and Switzerland, are against it.

"Canada has been silent," Lambert said. "They haven't actively blocked it, but they haven't proactively endorsed it either…. I would urge Canada, you know, just to show global leadership."

Airport personal unloaded the first batch of the AstraZeneca vaccines sent from the COVAX facility on March 28 in Pristina, Kosovo, the last country on the continent to start inoculation. (The Associated Press)

International Development Minister Karina Gould told As It Happens in an emailed statement that "as a government, it is our priority to take care of our own citizens."

"By investing early into COVAX to respond not only to international needs but also our own needs, we contributed to building trust in the mechanism to deliver and reinforced the mechanism's purchasing power as a whole," the statement reads. 

"It is incorrect to imply that for some reason, we would be delaying the delivery of those surplus vaccine doses. We are committed to making them available as quickly as possible."

For people in Canada, COVID-19 vaccines have offered increased protection from the virus and, in some cases, the ability to return in-person to work, school and social gatherings.

But for Lambert, that does not mean things are back to normal.

"As long as the rest of the world isn't vaccinated, this pandemic will go on," she said. "It creates fertile ground for the virus to mutate.

"It's really in everybody's interest to vaccinate the world, as soon as possible, so that we can just move on once and for all from this pandemic."

Written by Mehek Mazhar. Interview with Brittany Lambert produced by Katie Geleff.

Add some “good” to your morning and evening.

A variety of newsletters you'll love, delivered straight to you.

Sign up now


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Become a CBC Member

Join the conversation  Create account

Already have an account?